Citeline Podcasts
By Citeline
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Citeline
Category: Business
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 59
Reviews: 0
Episodes: 500
Description
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
| Episode | Date |
|---|---|
|
Drug Fix: BIOSECURE Act Advances, Trial Diversity Sticks, Platform Principles Without Designation
|
May 17, 2024 |
|
May 2024 Datamonitor Healthcare Podcast: Neoadjuvant Therapy in Melanoma
|
May 17, 2024 |
|
China Biotech Podcast - 15 May 2024 (Chinese- and English-Language)
|
May 15, 2024 |
|
Scrip's Five Must-Know Things - 13 May 2024
|
May 13, 2024 |
|
Episode 15: Digital Trust
|
May 09, 2024 |
|
Solving The Sustainable Pill Pack Puzzle, With PA Consulting’s Tony Perrotta
|
May 07, 2024 |
|
Scrip's Five Must-Know Things - 7 May 2024
|
May 07, 2024 |
|
Drug Fix: US FDA Adcomm Reform, A Boost For Clinical Trial Modeling, AI For Drug Review
|
May 03, 2024 |
|
Digital Health Roundup: US FDA’s ‘Idea Lab’; Philips’ Roy Jakobs On AI Draft Framework; Apple Watch
|
Apr 30, 2024 |
|
April Datamonitor Podcast 2024: AAN coverage
|
Apr 30, 2024 |
|
Scrip's Five Must-Know Things - 30 April 2024
|
Apr 30, 2024 |
|
2024 Global Generics & Biosimilars Awards
|
Apr 29, 2024 |
|
Podcast: Facilitating Patient Monitoring in CAR-T Development
|
Apr 29, 2024 |
|
Drug Fix: US FDA Biosimilar Strategy, Gene Therapy Accelerated Approvals, FDA v. Partisan Politics
|
Apr 26, 2024 |
|
Dr. Xue Discusses Treatment Guideline Updates for COPD in This Q&A Session
|
Apr 26, 2024 |
|
China Biotech Podcast - 26 April 2024 (Chinese and English Language)
|
Apr 26, 2024 |
|
Future Governance & Oversight of the EU Medtech Regulatory System
|
Apr 24, 2024 |
|
Citeline - Cerba Research Podcast V2
|
Apr 23, 2024 |
|
Scrip M&A Podcast: Are Buyers Coming For Viking, Verona, Altimmune, Xenon And Crinetics
|
Apr 23, 2024 |
|
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
|
Apr 22, 2024 |
|
Over The Counter 22 April 2024
|
Apr 22, 2024 |
|
Scrip's Five Must-Know Things - 22 April 2024
|
Apr 22, 2024 |
|
Drug Fix: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
|
Apr 19, 2024 |
|
Next-Generation Diagnostics: "Breathomics" From Imspex
|
Apr 19, 2024 |
|
Ratio Therapeutics On BMS Buy-In, Radiopharma R&D Trends, AI And Assets
|
Apr 16, 2024 |
|
China Biotech Podcast (Chinese- and English-language) - April 2024
|
Apr 15, 2024 |
|
Scrip's Five Must-Know Things - 15 April 2024
|
Apr 15, 2024 |
|
Drug Fix: US FDA Adcomm Open Public Hearings, Clinical Trial Diversity Plans, Stealth’s Elamipretide
|
Apr 12, 2024 |
|
In Conversation With 2024 In Vivo Rising Leader, Hanadie Yousef
|
Apr 09, 2024 |
|
Scrip's Five Must-Know Things - 8 April 2024
|
Apr 08, 2024 |
|
Drug Fix: Relyvrio And Public Promises, Allergy Biomarker Adcomms, PMDA In The USA
|
Apr 05, 2024 |
|
Medtech Connect Episode 14: Live From HIMSS 2024
|
Apr 03, 2024 |
|
피노바이오, 국내 ADC 생태계 발전에 기여할 것 (Korean-language podcast)
|
Apr 02, 2024 |
|
Scrip's Five Must-Know Things - 1 April 2024
|
Apr 01, 2024 |
|
Analysing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
|
Mar 28, 2024 |
|
March Datamonitor Podcast 2024: The US Inflation Reduction Act
|
Mar 27, 2024 |
|
Scrip's Five Must-Know Things - 26 March 2024
|
Mar 26, 2024 |
|
Drug Fix: Mifepristone And Misinformation At SCOTUS, Understanding US FDA’s ODAC
|
Mar 22, 2024 |
|
China Biotech Podcast (Chinese language) - March 2024
|
Mar 22, 2024 |
|
Digital Health Roundup: EU’s AI Act Impact; Verily's Andrew Trister’s Vision For Personal AI Agent
|
Mar 20, 2024 |
|
Scrip's Five Must-Know Things - 18 March 2024
|
Mar 18, 2024 |
|
Over The Counter 18 March 2024 1
|
Mar 15, 2024 |
|
【3分で解説 世界のファーマ】第17回 LSDで不安症を治療 第III相開始へ (Japanese-language podcast)
|
Mar 13, 2024 |
|
"Identifying The 80% Of Undiagnosed And Misdiagnosed Patients"
|
Mar 11, 2024 |
|
Scrip's Five Must-Know Things - 11 March 2024
|
Mar 11, 2024 |
|
Drug Fix: Vanda Appeals US FDA Jet Lag Denial In Court, Mark Cuban Battles PBMs, Austere FDA Budget
|
Mar 08, 2024 |
|
Scrip이 묻다: 2024년 제약바이오업계 전망은? 치료영역의 발전 (Korean-language podcast)
|
Mar 07, 2024 |
|
Medtech Connect Episode 13: Augmented Reality In Surgery
|
Mar 07, 2024 |
|
Scrip's Five Must-Know Things - 4 March 2024
|
Mar 04, 2024 |
|
Cardio Conversations: iRhythm CEO Blackford Talks AI Arrhythmia Diagnostics
|
Mar 04, 2024 |
|
The Emerging Benefits Of ‘Beauty-From-Within,’ Featuring Kenvue’s Paul LaTerra
|
Mar 01, 2024 |
|
February Datamonitor Podcast: 2024 Clinical Outlook
|
Feb 28, 2024 |
|
NodThera On The Role Of The Brain In Driving Chronic Disease
|
Feb 28, 2024 |
|
Scrip's Five Must-Know Things - 26 February 2024
|
Feb 26, 2024 |
|
Drug Fix: US FDA And Psychedelic Drugs, Aduhelm Clinical Trial Data, Adcomm Candidates
|
Feb 23, 2024 |
|
AESGP’s 60th Birthday Celebrations In 2024 Including Annual Meeting, With Jurate Švarcaite
|
Feb 20, 2024 |
|
Drug Fix: Price Negotiation Suit Tossed, Drug Shortage Probe, FDA-Approved Marijuana
|
Feb 16, 2024 |
|
Drug Fix: State Of The Generic Industry, US FDA Under Second Trump Term, Inspections And Shortages
|
Feb 09, 2024 |
|
China Biotech Podcast (Chinese and English Language) - February 2024
|
Feb 08, 2024 |
|
혁신 육성 전략에 기반한 한국의 제약바이오 강국 야망 (Korean-language podcast)
|
Feb 07, 2024 |
|
Trio Of Diagnostics Execs Weigh In On Upcoming Challenges
|
Feb 06, 2024 |
|
China Biotech Podcast - Interview With BeiGene Co-Founder Xiaodong Wang
|
Feb 06, 2024 |
|
Title: The Promise Of AI For Consumer Health, Pt 2, With The Exponential Club’s Nick Tate
|
Feb 05, 2024 |
|
Scrip's Five Must-Know Things - 5 February 2024
|
Feb 05, 2024 |
|
Digital Health Roundup: CES Biggest Hits; Apple Versus Masimo; Insulet Recalls Diabetes App
|
Jan 30, 2024 |
|
Automating Cell Therapy Manufacturing: Cellular Origins' CEO Talks Robotics
|
Jan 29, 2024 |
|
Scrip's Five Must-Know Things - 29 January 2024
|
Jan 29, 2024 |
|
Medtech Connect Episode 12: Apple’s Patent Infringement Cases
|
Jan 26, 2024 |
|
Drug Fix: Janet Woodcock And The US FDA’s G.O.A.T., Puberty Blockers Meeting, CAR-T Safety
|
Jan 26, 2024 |
|
Q&A Session on Treatment of LBCL With Oncologist Donald Fleming, MD
|
Jan 22, 2024 |
|
Over The Counter 22 Jan 2023
|
Jan 22, 2024 |
|
Drug Fix: US FDA Adcomm Schedule, CMS And Drug Importation, Missed User Fee Goals
|
Jan 19, 2024 |
|
China Biotech Podcast - Major Takeaways From JPM (January 2024 - Chinese-Language)
|
Jan 19, 2024 |
|
【3分で解説 世界のファーマ】第16回 JPモルガンで見えた2024年の製薬業界 (Japanese-language podcast)
|
Jan 19, 2024 |
|
Scrip's Five Must-Know Things - 15 January 2024
|
Jan 15, 2024 |
|
Pennine Health Talks Sustainability Compliance and ESG Initiatives
|
Jan 12, 2024 |
|
Drug Fix: Project Orbis For Gene Therapy, US FDA Leaders’ 2024 Predictions, FDA and AI
|
Jan 12, 2024 |
|
Building A Biotech: Exploring ILC’s Hybrid Interferon Platform
|
Jan 11, 2024 |
|
전 세계 비만 치료제 임상시험 건 수, 미국이 가장 높아…한국은 9위 (Korean-language podcast)
|
Jan 11, 2024 |
|
Scrip's Five Must-Know Things - 10 January 2024
|
Jan 10, 2024 |
|
Podcast: Current trends in the biotech landscape with Chris Smyth, President, ICON Biotech Solutions
|
Jan 09, 2024 |
|
China Biotech Podcast - January 2024 (Chinese-language)
|
Jan 09, 2024 |
|
Cardio Conversations: AVS Cracks Calcium With Novel Pressure Wave Balloon
|
Jan 05, 2024 |
|
Drug Fix: Looking Back And Looking Ahead: Key US and EU Legislation
|
Jan 05, 2024 |
|
Unlock the Future of Cancer Detection with Dr Charles P. Vega, MD, FAAFP: Listen Now!
|
Jan 03, 2024 |
|
The Challenges of Rare Neurological Disease Drug Development
|
Dec 22, 2023 |
|
【3分で解説 世界のファーマ】第15回 治験に被験者の「多様性」を 米国の課題 (Japanese-language podcast)
|
Dec 22, 2023 |
|
Medtech Connect Episode 11: A Look Back At 2023
|
Dec 20, 2023 |
|
Biopharma’s Must-Know 2023-4 Catalysts
|
Dec 20, 2023 |
|
Scrip’s Five Must-Know Things – 19 December 2023
|
Dec 19, 2023 |
|
Drug Fix: Taking A Look Back, And Forward, With US FDA’s Project Orbis
|
Dec 15, 2023 |
|
China Biotech Podcast - December 2023 (Chinese-language)
|
Dec 14, 2023 |
|
Scrip’s Five Must-Know Things – 11 December 2023
|
Dec 11, 2023 |
|
Over the Counter 7 Dec 2023: IFRA On Potential Impact Of EU's CLP Revision
|
Dec 07, 2023 |
|
제약업계의 생성형AI 적용 성공의 열쇠는? (Korean-language podcast)
|
Dec 05, 2023 |
|
Scrip's Five Must-Know Things - 4 December 2023
|
Dec 04, 2023 |
|
Drug Fix: CAR-T Malignancy Reports, Background Music In DTC Ads, New No. 2 At US FDA
|
Dec 01, 2023 |
|
RNA And Kidneys And Diagnostics RNA, Oh My – Discussing Verici DX’s Differentiated Product Offering
|
Nov 27, 2023 |
|
Scrip’s Five Must-Know Things – 27 November 2023
|
Nov 27, 2023 |
|
Trends In Epidemiology
|
Nov 23, 2023 |
|
Scrip Lifetime Achievement Award 2023: Jeremy Levin’s Acceptance Speech
|
Nov 22, 2023 |
|
China Biotech Podcast (Chinese language) - November 2023
|
Nov 21, 2023 |
|
Discussing The Potentials Of And Challenges For Digital Therapeutics
|
Nov 21, 2023 |
|
Digital Health Roundup: Black Friday Hits – Digital Twins, Biowearables, Robotics, Cardiology
|
Nov 21, 2023 |
|
Scrip’s Five Must-Know Things – 20 November 2023
|
Nov 20, 2023 |
|
Drug Fix: Janet Woodcock retiring, Accelerated Approval Reform, US FDA Meeting Recording Policy
|
Nov 17, 2023 |
|
Syngene CEO On Sub-Dynamics As US Biotech Funding Finds New Normal, ADC Capabilities
|
Nov 17, 2023 |
|
Scrip’s Five Must-Know Things – 13 November 2023
|
Nov 13, 2023 |
|
Drug Fix: FTC Orange Book Patent Challenges, Ad/Promo Due Diligence, US FDA Adcomm Decision Appeal
|
Nov 10, 2023 |
|
How OTC Companies Can Respond To Preventative Health Trends - With Simon Kucher & Partners
|
Nov 10, 2023 |
|
Humira Biosimilar Landscape Podcast
|
Nov 08, 2023 |
|
일본 최대 바이오클러스터, 한국 바이오벤처들과 CGT 협업 추진 (Korean-language podcast)
|
Nov 07, 2023 |
|
Scrip’s Five Must-Know Things – 6 November 2023
|
Nov 06, 2023 |
|
Drug Fix: CMS Listens On Price Negotiations, Elevidys Top-Line Trial Data, Gene Therapy Reg Changes
|
Nov 03, 2023 |
|
【3分で解説 世界のファーマ】第14回 承認２カ月後に新薬発売へ、スイスの新制度 (Japanese-language podcast)
|
Nov 02, 2023 |
|
Podcast: Overcoming regulatory challenges in a complex clinical trial landscape
|
Nov 01, 2023 |
|
Biotech CEO Podcast with William Wei Cao of Gracell Bio
|
Nov 01, 2023 |
|
China Biotech Podcast (Chinese language) - October 2023
|
Oct 31, 2023 |
|
Scrip’s Five Must-Know Things – 30 October 2023
|
Oct 30, 2023 |
|
Drug Fix: Off-Label Coms Guidance, Price Negotiations And Prescribing, Bertagnolli’s NIH Bid
|
Oct 27, 2023 |
|
AI In Behavioral Health Clinics
|
Oct 25, 2023 |
|
Over The Counter 24 Oct 2023: An Approach To MoCRA With Good Face Project’s Iva Teixeira
|
Oct 24, 2023 |
|
Scrip’s Five Must-Know Things – 23 October 2023
|
Oct 23, 2023 |
|
Drug Fix: BrainStorm Withdraws NurOwn, NIH Nominee On Drug Pricing, Gene Therapy Long-Term Follow-Up
|
Oct 20, 2023 |
|
Medtech Insight: The Realities Of Real-World Evidence.
|
Oct 18, 2023 |
|
Q&A with Dr. Marc Sandberg: A Specialist in Endocrinology, Diabetes & Metabolism
|
Oct 18, 2023 |
|
Centrient Delivers Innovation In Biotechnology
|
Oct 17, 2023 |
|
Q&A with Sleep Medicine Specialist Nathaniel Watson, MD
|
Oct 16, 2023 |
|
Scrip’s Five Must-Know Things – 16 October 2023
|
Oct 16, 2023 |
|
Drug Fix: US FDA Suffers From Shutdown Threat, Alnylam’s CR Letter, ARPA-H Wants FDA Incentives
|
Oct 13, 2023 |
|
Scrip’s Five Must-Know Things – 11 October 2023
|
Oct 11, 2023 |
|
아일랜드, 글로벌 제약사의 투자처로 각광 (Korean-language podcast)
|
Oct 09, 2023 |
|
What’s Going On With Oral Phenylephrine In The US? With HBW’s Malcolm Spicer
|
Oct 06, 2023 |
|
Medtech Connect Episode 10: Breaking Down The Transitional Coverage Of Emerging Technologies
|
Oct 04, 2023 |
|
Scrip’s Five Must-Know Things – 3 October 2023
|
Oct 03, 2023 |
|
Scrip M&A Podcast: US FTC Review of Mergers and Acquisitions
|
Oct 02, 2023 |
|
Drug Fix: Adcomm Rejects NurOwn For ALS, FDA In Shutdown Mode, Limited Price Negotiation Savings
|
Sep 29, 2023 |
|
Scrip’s Five Must-Know Things – 28 September 2023
|
Sep 28, 2023 |
|
Disrupting the Consumer Health Industry, With Maxwellia’s Anna Maxwell
|
Sep 25, 2023 |
|
Insitro’s Daphne Koller On The Marriage Of Biology And Machine Learning At The Company’s Heart
|
Sep 25, 2023 |
|
Scrip’s Five Must-Know Things – 20 September 2023
|
Sep 20, 2023 |
|
Drug Fix: Regeneron’s COVID Monoclonal Deal, New FDA Advisor, Project Optimus In Cancer Combos
|
Sep 15, 2023 |
|
Scrip’s Five Must-Know Things – 13 September 2023
|
Sep 13, 2023 |
|
Trends Shaping The OTC Industry Today, With BSS Consulting’s Birgit Schuhbauer
|
Sep 11, 2023 |
|
지피지기면 백전백승” 대웅이노베이션의 미국시장 전략 (Korean-language podcast)
|
Sep 11, 2023 |
|
Drug Fix: FTC Ends Amgen-Horizon Case, New Ultra-Rare Cancer Partnership, Generic Applications Lag
|
Sep 08, 2023 |
|
Medtech Connect Episode 9: The Intersection Of IVDs And Digital Health
|
Sep 07, 2023 |
|
Dr Reddy’s MD On The Next Horizon, Owner-Managed Firms, Life Lessons From Birds
|
Sep 07, 2023 |
|
Creating A Digital Biotech Story
|
Sep 06, 2023 |
|
Scrip’s Five Must-Know Things – 4 September 2023
|
Sep 04, 2023 |
|
Digital Health Roundup: VR, AI Trends In Rehabilitation; Cybersecurity Regulations; Medicare Updates
|
Sep 01, 2023 |
|
Drug Fix: What We Learned From The First Medicare Price Negotiation List, Pepaxto Withdrawal Update
|
Sep 01, 2023 |
|
China Biotech CEO Interview with Hua Medicine’s Li Chen
|
Sep 01, 2023 |
|
Emergex CEO Questions mRNA Vaccines Against ‘Wuhan Virus’, Works On Universal Vaccines
|
Aug 31, 2023 |
|
Podcast: Operationalizing Decentralized Clinical Trials
|
Aug 30, 2023 |
|
How To Be A Consumer Health Leader, With BSS Consulting’s Birgit Schuhbauer
|
Aug 29, 2023 |
|
Fourth Time Lucky: How Mithra’s Novel Estrogen E4 Is Disrupting The Women’s Health Market
|
Aug 29, 2023 |
|
Scrip’s Five Must-Know Things – 28 August 2023
|
Aug 28, 2023 |
|
China Biotech Podcast - August 2023 (Chinese-language)
|
Aug 24, 2023 |
|
Scrip’s Five Must-Know Things – 21 August 2023
|
Aug 21, 2023 |
|
Drug Fix: Medicare Price Negotiation List Preview, Mifepristone Ruling, AZ Sales Aid Warning Letter
|
Aug 18, 2023 |
|
UK OTC Marketing Awards Judge On What Makes A Standout Entry, With PAGB's Michelle Riddalls
|
Aug 14, 2023 |
|
Scrip’s Five Must-Know Things – 14 August 2023
|
Aug 14, 2023 |
|
Drug Fix: Wegovy’s CV Benefits, Mifepristone And Water Contamination, US FDA Back To The Office?
|
Aug 11, 2023 |
|
【3分で解説 世界のファーマ】第13回 薬価めぐり違憲訴訟へ 米国、インフレ抑制法 (Japanese-language podcast)
|
Aug 09, 2023 |
|
What Happens To Software As A Medical Device Under The EU AI Act? With Bristows’ Jamie Hatzel
|
Aug 07, 2023 |
|
Scrip’s Five Must-Know Things – 31 July 2023
|
Aug 07, 2023 |
|
Drug Fix Special: Assessing US FDA Advisory Committee Reform Proposals
|
Aug 04, 2023 |
|
How The Eudamed Medical Device Database Is Progressing Slowly But Surely And the Challenges Ahead
|
Aug 04, 2023 |
|
일본 항암제, CNS 치료제, 미국시장서 높은 허가가능성 보여 (Korean-language podcast)
|
Aug 03, 2023 |
|
Medtech Connect Episode 8: Exploring Regulatory Differences In The EU And US
|
Aug 03, 2023 |
|
Scrip’s Five Must-Know Things – 31 July 2023
|
Jul 31, 2023 |
|
CEO Of Cell Therapy Firm Stempeutics Talks Partnerships In Japan, Changes In India Trials Regulation
|
Jul 28, 2023 |
|
China Biotech Podcast - July 2023 (Chinese language)
|
Jul 28, 2023 |
|
Digital Health Roundup: What’s Hot On Investment; Diabetes; AI
|
Jul 27, 2023 |
|
A Digital Marketplace Aims To Make Asset Acquisition Frictionless
|
Jul 27, 2023 |
|
What's ‘Software As A Medical Device’ And How Is It Regulated In The EU? With Bristows’ Jamie Hatzel
|
Jul 24, 2023 |
|
Meeting Milestones Through Effective Biotech Trial Strategies Episode 2
|
Jul 20, 2023 |
|
Meeting Milestones Through Effective Biotech Trial Strategies Episode 1
|
Jul 20, 2023 |
|
Will A ‘Netflix’ Model Solve Antibiotic Reimbursement Challenges And Spur R&D?
|
Jul 19, 2023 |
|
How Downturn In Demand For EU Medtech Regulatory Talent Is Starting To Improve
|
Jul 18, 2023 |
|
Scrip’s Five Must-Know Things – 18 July 2023
|
Jul 18, 2023 |
|
Q&A with Retina Specialist
|
Jul 14, 2023 |
|
MDR Amending Regulation Eases Stress Of EU Medtech Stakeholders As Processes Improve
|
Jul 12, 2023 |
|
【3分で解説 世界のファーマ】第12回 ChatGPT、製薬業界でも実証実験 (Japanese-language podcast)
|
Jul 10, 2023 |
|
Q&A with Bladder Cancer Specialist
|
Jul 10, 2023 |
|
Scrip’s Five Must-Know Things – 10 July 2023
|
Jul 10, 2023 |
|
Prescription Slimming Drugs And Their OTC Alternatives, With OptiBiotix’s Stephen O’Hara
|
Jul 07, 2023 |
|
이모코그, 치매 디지털치료제의 기준을 세우다 (Korean-language podcast)
|
Jul 07, 2023 |
|
Cardio Conversations: Volta Has Big Ambitions For AI In EP
|
Jul 06, 2023 |
|
No Valid excuses For Manufacturers To Delay IVD Regulation Applications
|
Jul 05, 2023 |
|
Medtech Connect Episode 7: Decentralized Clinical Trials
|
Jul 03, 2023 |
|
Scrip’s Five Must-Know Things – 3 July 2023
|
Jul 03, 2023 |
|
China Biotech Podcast - 30 June 2023
|
Jun 30, 2023 |
|
Digital Health Round-Up: DTA 2023 Highlights; Pear Assets; Medtronic’s Spin-Off; New Business
|
Jun 28, 2023 |
|
Scrip’s Five Must-Know Things – 26 June 2023
|
Jun 26, 2023 |
|
What You Need To Know About The EU Green Claims Directive, With PHD’s Jo Stephenson
|
Jun 24, 2023 |
|
Median: The Competitive Advantages of AI-Powered Clinical Trial Imaging to Advance Human Health
|
Jun 23, 2023 |
|
Post-ASCO Podcast
|
Jun 22, 2023 |
|
Global Generics & Biosimilars Awards 2023 Podcast
|
Jun 22, 2023 |
|
Scrip’s Five Must-Know Things – 20 June 2023
|
Jun 20, 2023 |
|
Drug Fix: COVID-19 Vaccine Strain Selection, Small FDA Advisory Committees, OPDP Untitled Letter
|
Jun 16, 2023 |
|
【3分で解説 世界のファーマ】第11回 「大企業ほど承認申請に強い」説、過去2年分のデータで証明 (Japanese-language podcast)
|
Jun 13, 2023 |
|
Scrip’s Five Must-Know Things – 12 June 2023
|
Jun 12, 2023 |
|
China Biotech Podcast on ASCO 2023
|
Jun 09, 2023 |
|
Over The Counter 9 June 2023: Embracing AI/AR Evolution In Beauty, While Navigating Its Hurdles
|
Jun 08, 2023 |
|
Medtech Connect Episode 6: The Latest And Greatest In Digital Health Regulations
|
Jun 07, 2023 |
|
항서제약에서 모더나까지: 바이오 기업들이 스위스로 몰리고 있는 이유 (Korean-language podcast)
|
Jun 06, 2023 |
|
Scrip’s Five Must-Know Things – 5 June 2023
|
Jun 05, 2023 |
|
Drug Fix: Alzheimer’s Drugs, US FDA’s New Patient Info Leaflet, COVID-19 Vaccine Harmonization
|
Jun 02, 2023 |
|
Antibody-drug Conjugate Podcast
|
May 31, 2023 |
|
“Marketing Applications: Best Practices for Publishing”
|
May 31, 2023 |
|
“From Benchtop to IND: CMC Pitfalls”
|
May 31, 2023 |
|
Diversity, Equity, and Inclusion Measures Continue to Evolve in the Clinical Space
|
May 31, 2023 |
|
Scrip’s Five Must-Know Things – 29 May 2023
|
May 29, 2023 |
|
Drug Fix: Big Pharma’s US FDA Scorecard, Sarepta’s DMD Gene Therapy Delay, US FDA Adcomm Reforms
|
May 26, 2023 |
|
What You Need To Know About HRA/Perrigo’s Historic US OTC Pill Switch With HBW’s Malcolm Spicer
|
May 22, 2023 |
|
Scrip’s Five Must-Know Things – 22 May 2023
|
May 22, 2023 |
|
China Biotech Podcast051623
|
May 17, 2023 |
|
Digital Health Roundup: HIMSS, Cardio Conversations, ChatGPT And New FDA Guidances
|
May 15, 2023 |
|
Scrip’s Five Must-Know Things – 15 May 2023
|
May 15, 2023 |
|
Cardio Conversations: iRhythm Aspires To ‘Standard-Of-Care’ Monitoring
|
May 10, 2023 |
|
동아ST에 새로운 변화의 물결이 일다 (Korean-language podcast)
|
May 10, 2023 |
|
Progressing The Global Self-Care Industry’s Sustainability Agenda With GSCF’s Padmaja Kamath
|
May 09, 2023 |
|
Scrip’s Five Must-Know Things – 8 May 2023
|
May 08, 2023 |
|
Scrip M&A Podcast: Pfizer/Seagen and What May Follow
|
May 05, 2023 |
|
Q&A with Lung Cancer Specialist
|
May 04, 2023 |
|
Maximizing The UK Medtech Opportunity In Times Of Change
|
May 03, 2023 |
|
Medtech Connect Episode 5: EU Horizontal Regulations And Digital Tech
|
May 03, 2023 |
|
Scrip’s Five Must-Know Things – 1 May 2023
|
May 01, 2023 |
|
Why Sustainability Is The Only Sustainable Business Model, With Bayer’s Daniella Foster
|
Apr 25, 2023 |
|
Scrip’s Five Must-Know Things – 24 April 2023
|
Apr 24, 2023 |
|
Drug Fix: Sarepta DMD Gene Therapy Issues, New COVID-19 Vaccine Schedule, Medicare Price Negotiation
|
Apr 21, 2023 |
|
DMHC podcast: Neurodegenerative Disorders
|
Apr 21, 2023 |
|
Biotech CEO podcast with Huahui CSO Li Wenhui
|
Apr 21, 2023 |
|
HPV Vaccines – The Journey So Far And Long Road Ahead
|
Apr 21, 2023 |
|
【3分で解説 世界のファーマ】第10回 どうなるミフェプリストン承認 米国FDAが裁判に危機感 (Japanese-language podcast)
|
Apr 19, 2023 |
|
China Biotech Podcast0412
|
Apr 18, 2023 |
|
Scrip’s Five Must-Know Things – 17 April 2023
|
Apr 17, 2023 |
|
Cardio Conversations: Vektor Addresses ‘Global Health Crisis’ With Arrythmia Mapping
|
Apr 14, 2023 |
|
Pharma R&D Annual Review 2023 - Chapter 7: Epilogue; Where next for the Pharma Saga?
|
Apr 14, 2023 |
|
Pharma R&D Annual Review 2023 - Chapter 6: Modus Operandi; Types of Pipeline Drugs
|
Apr 14, 2023 |
|
Pharma R&D Annual Review 2023 - Chapter 5: Deus Ex Machina; Mechanisms and Targets
|
Apr 14, 2023 |
|
Pharma R&D Annual Review 2023 - Chapter 4: The Motivations Propelling Events; Top Therapies
|
Apr 14, 2023 |
|
Pharma R&D Annual Review 2023 - Chapter 3: Dramatis Personae; Top Companies
|
Apr 14, 2023 |
|
Pharma R&D Annual Review 2023 - Chapter 2: Setting the Scene; The 2023 Pipeline by Phase
|
Apr 14, 2023 |
|
Pharma R&D Annual Review 2023 - Chapter 1: Total Pipeline Size
|
Apr 14, 2023 |
|
Pharma R&D Annual Review 2023 - Introduction
|
Apr 14, 2023 |
|
Pharma R&D Annual Review 2023 - About the Author
|
Apr 14, 2023 |
|
Q&A with Heart Failure Specialist
|
Apr 13, 2023 |
|
Pharma R&D Annual Review 2023 - Introduction
|
Apr 13, 2023 |
|
Pharma R&D Annual Review 2023 - ABOUT THE AUTHOR
|
Apr 13, 2023 |
|
Digital Health Roundup: Voice Biomarkers; SXSW, LSI, ACC; FTC BetterHelp Settlement
|
Apr 11, 2023 |
|
Scrip’s Five Must-Know Things – 10 April 2023
|
Apr 10, 2023 |
|
Medtech Connect Episode 4: Intelligent Devices
|
Apr 07, 2023 |
|
A Man On Fire Fueled By A Mission To Find A Drug For Every Disease.
|
Apr 05, 2023 |
|
Veristat: Advancing Revolutionary Therapies (ART): Orphan Drug Designations and Orphan Subsets
|
Apr 05, 2023 |
|
글로벌 빅파마와의 접촉은 빠를수록 좋다 (Korean-language podcast)
|
Apr 03, 2023 |
|
Scrip’s Five Must-Know Things – 3 April 2023
|
Apr 03, 2023 |
|
Drug Fix: BrainStorm’s ALS Adcomm, Batch Testing Imported Drugs, US FDA’s First In-Person Meeting
|
Mar 31, 2023 |
|
DMHC podcast - Advanced Therapies
|
Mar 30, 2023 |
|
Podcast Special: J&J's Andrie Leday Addresses ASCs With Customized Approach
|
Mar 28, 2023 |
|
Scrip’s Five Must-Know Things – 27 March 2023
|
Mar 27, 2023 |
|
Drug Fix: Moderna CEO On Capitol Hill, Xtandi March-In Rights, Tofersen Adcomm In ALS
|
Mar 24, 2023 |
|
Getting Personal With Brittany Barreto: From One-Time ‘Science Hater’ To Women’s Health Champion
|
Mar 20, 2023 |
|
The Shape Of The Global OTC Market To Come, With IQVIA CH’s Amit Shukla
|
Mar 20, 2023 |
|
Drug Fix: Medicare Inflation Rebates And Negotiation, Leqembi Reimbursement, FDA Gene Therapy Chief
|
Mar 17, 2023 |
|
German Hospital Reform Ushers In A Reimbursement ‘Revolution’
|
Mar 13, 2023 |
|
【3分で解説 世界のファーマ】第9回 中国企業が急成長 CLDN18.2抗体市場のいま (Japanese-language podcast)
|
Mar 10, 2023 |
|
Cardio Conversations: Abbott Aspires To Build 'Future Ready' CRM Devices
|
Mar 09, 2023 |
|
KDDF의 ‘대어 사냥’ (Korean-language podcast)
|
Mar 09, 2023 |
|
ICON: Increasing diversity in clinical research trials
|
Mar 09, 2023 |
|
Digital Health Roundup: Omar Ishrak’s SPAC; AI In Dermatology, IVF, Imaging; Wellness Apps
|
Mar 08, 2023 |
|
Medtech Connect Episode 3: A Deep-Dive Into FDA’s Cyber Reforms
|
Mar 06, 2023 |
|
How Automation is Able to Transform CSV through eQMS
|
Mar 06, 2023 |
|
How AI Is Evolving In The Industry By Increasing The Quality Of Data Being Used
|
Mar 06, 2023 |
|
How to Successfully Deploy a Fully Integrated eQMS
|
Mar 06, 2023 |
|
A Guide To Post-Pandemic Consumer Healthcare Marketing, With Kaizo’s Kerry Lennox
|
Mar 06, 2023 |
|
Drug Fix: RSV Vaccine Questions, Lilly Lowers Insulin Cost, Orphan Drug Act Changes
|
Mar 03, 2023 |
|
Cardio Conversations: Abbott's EP CMO Christopher Piorkowski Talks Mapping, PFA And More
|
Mar 02, 2023 |
|
Getting Personal With Boston’s Scientific Global CMO Ken Stein: Taking The Long View To Innovate
|
Mar 02, 2023 |
|
hVIVO’s Andrew Catchpole Talks Human Challenge Trials, From COVID-19 to Malaria
|
Mar 01, 2023 |
|
China Biotech Podcast20230228
|
Mar 01, 2023 |
|
Drug Fix: State Of The Generics Industry, US FDA Adcomm Reforms, EUAs Outside COVID-19
|
Feb 24, 2023 |
|
OxSonics Hopes To Use Ultrasound To Enhance Drug Efficacy – Without Reformulation
|
Feb 23, 2023 |
|
Biotech CEO interview on AI assisted Drug Discovery with Insilico Co-CEO Feng Ren
|
Feb 23, 2023 |
|
Reframing Site & PI Selection Through Lab Data - Part 2
|
Feb 21, 2023 |
|
Reframing Site & PI Selection Through Lab Data - Part 1
|
Feb 21, 2023 |
|
Akeso Chairwoman Michelle Xia Podcast 20230221
|
Feb 21, 2023 |
|
What To Expect From The 59th AESGP Annual Meeting, With Jurate Švarcaite
|
Feb 20, 2023 |
|
Scrip’s Five Must-Know Things – 20 February 2023
|
Feb 20, 2023 |
|
Scrip’s Five Must-Know Things – 13 February 2023
|
Feb 13, 2023 |
|
Drug Fix: Limiting Medicare Price Negotiation, More US FDA Adcomm And COVID-19 Vaccine Concerns
|
Feb 10, 2023 |
|
Launch of Citeline Pharma Intelligence Awards Japan 2023 (Bilingual Podcast)
|
Feb 10, 2023 |
|
The future of mifepristone in America, with professor Greer Donley
|
Feb 08, 2023 |
|
DMHC’s financial analysts discuss M&As, the vaccine market, and biosimilars
|
Feb 08, 2023 |
|
2023년 글로벌 제약바이오 업계에 무슨 일이?
|
Feb 07, 2023 |
|
Inside medical research charity LifeArc, with CEO Melanie Lee
|
Feb 07, 2023 |
|
Prebiotics And Consumer Health: Opportunity, Regulation and Future, With Clasado’s Per Rehné
|
Feb 06, 2023 |
|
Scrip’s Five Must-Know Things – 6 February 2023
|
Feb 06, 2023 |
|
Drug Fix: US FDA Loses Gene Therapy Expert, Humira Biosimilars Launch, FDA Allows In-Person Meetings
|
Feb 03, 2023 |
|
Medtech Connect: MedTech Europe's Alexander Olbrechts On The European Health Data Space
|
Feb 03, 2023 |
|
Interview with Neil Warma, president and CEO of Genexine
|
Feb 01, 2023 |
|
Biotech Is Solving Beauty’s Sustainability Challenges, Elevating R&D, With Amyris’ Annie Tsong
|
Feb 01, 2023 |
|
【3分で解説 世界のファーマ】第8回 2023年JPモルガン・ヘルスケアカンファレンス 3つの焦点とは
|
Feb 01, 2023 |
|
Scrip’s Five Must-Know Things – 30 January 2023
|
Jan 30, 2023 |
|
Eli Lilly’s Diogo Rau on the company’s digital future
|
Jan 27, 2023 |
|
Mavacamten in oHCM: Q&A with Cardiology Specialist, Lynn Cronin, MD
|
Jan 25, 2023 |
|
Digital Health Roundup: CES 2023 Highlights; US FDA VR, AR Website; Bayer’s Powers Up On Radiology
|
Jan 25, 2023 |
|
Digital Health Roundup: CES 2023 Highlights; US FDA VR, AR Website; Bayer’s Powers Up On Radiology
|
Jan 24, 2023 |
|
Panthera Biopartners Discuss The SMO Strategy
|
Jan 24, 2023 |
|
Scrip’s Five Must-Know Things – 23 January 2023
|
Jan 23, 2023 |
|
Cardio Conversations: Interview With PFA Pioneer Steven Mickelsen
|
Jan 21, 2023 |
|
Medtech Monthly: Eargo CEO Discusses OTC Hearing Aids.
|
Jan 20, 2023 |
|
Drug Fix: More US FDA Communication Problems, 2022 Approval Trends, Cancer Drug Dosing Guidance
|
Jan 20, 2023 |
|
Post - ASH Podcast
|
Jan 20, 2023 |
|
Scrip’s Five Must-Know Things – 16 January 2023
|
Jan 16, 2023 |
|
Drug Fix: Leqembi Approved, Medicare Price Negotiation Timeline, AAM CEO Departure
|
Jan 13, 2023 |
|
Medtech Connect Episode 1: How Do We Regulate Software As A Medical Device?
|
Jan 06, 2023 |
|
2022년 글로벌 제약업계 5대 뉴스는? (Korean-language podcast)
|
Jan 04, 2023 |
|
China Podcast
|
Dec 22, 2022 |
|
CLP, Cosmetics And New Hazard Classes In The EU’s Haste To Be Green, With Louise Witter
|
Dec 19, 2022 |
|
Medtech Insight’s Medtech 100 and 2023 Industry Outlook
|
Dec 16, 2022 |
|
Drug Fix: Accelerated Approvals Drop, CMS’s Generic Tiers Reg, Cytokinetics’ Adcomm Loss
|
Dec 16, 2022 |
|
Citeline Awards 2023 - Entry hints and tips podcast
|
Dec 15, 2022 |
|
レポート要約2／2021年の臨床試験の総括、ポストパンデミックの世界はニューノーマルを迎えたのか (Japanese-language podcast)
|
Dec 13, 2022 |
|
SK바이오팜 CTO: 오픈이노베이션의 다양성 (Korean-language podcast)
|
Dec 13, 2022 |
|
Scrip’s Five Must-Know Things – 12 December 2022
|
Dec 12, 2022 |
|
Drug Fix: Innovation v. Access, AAM CEO Departs, Concerns About US FDA’s IND Regulations
|
Dec 09, 2022 |
|
Scrip’s Five Must-Know Things – 5 December 2022
|
Dec 05, 2022 |
|
Vision Possible: Why Eyestem Is ‘Bullish’ About Its Dry AMD Candidate
|
Nov 30, 2022 |
|
Digital Health Roundup: HLTH2022 Highlights, EU Updates, Diabetes Medtech Monthly
|
Nov 29, 2022 |
|
3分で解説 世界のファーマ】第7回 米国で見えてきたRWDの注意点
|
Nov 29, 2022 |
|
Scrip’s Five Must-Know Things – 28 November 2022
|
Nov 28, 2022 |
|
Scrip’s Five Must-Know Things – 21 November 2022
|
Nov 21, 2022 |
|
Harbour BioMed CEO Podcast20221118
|
Nov 18, 2022 |
|
Vaxxinity CEO On Getting Rid Of Alzheimer’s And Migraines, Preventing Heart Disease And COVID-19
|
Nov 18, 2022 |
|
レポート要約 - 1] 臨床試験を牽引するアジア太平洋地域
|
Nov 16, 2022 |
|
2022년 빅파마M&A 선두주자는 화이자, 인수합병 또 나올까?
|
Nov 13, 2022 |
|
Drug Fix: Election Fallout, IRA Impacting Product Development, Updated FDA Expanded Access Policy
|
Nov 11, 2022 |
|
Accenture's Petra Jantzer on M&A trends and what it means for execs
|
Nov 08, 2022 |
|
Scrip’s Five Must-Know Things – 7 November 2022
|
Nov 07, 2022 |
|
How IVI Is Helping To Shape Korea’s Vaccine Ambitions
|
Nov 04, 2022 |
|
Medtech Monthly, Ep. 4: The Future Of Diabetes Tech
|
Nov 01, 2022 |
|
Scrip’s Five Must-Know Things – 31 October 2022
|
Oct 31, 2022 |
|
China Biotech Podcast102822
|
Oct 28, 2022 |
|
Scrip’s Five Must-Know Things – 24 October 2022
|
Oct 24, 2022 |
|
Getting Personal With Avail Medsystems’ Daniel Hawkins Who Has Entrepreneurship In His Blood
|
Oct 21, 2022 |
|
Drug Fix: Makena Hearing Lessons, Sponsors’ Accelerated Approval Failings, US FDA Claims Enforcement
|
Oct 21, 2022 |
|
Digital Health Roundup: Telehealth Strong, Diabetes Recalls And Expansions, AI And Radiology
|
Oct 19, 2022 |
|
Getting Personal With Edwards’ Mike Mussallem: Hard Work, Giving Back, Changing Practice Of Medicine
|
Oct 17, 2022 |
|
Scrip’s Five Must-Know Things – 17 October 2022
|
Oct 17, 2022 |
|
Drug Fix: BIO CEO Departs, Makena Withdrawal Hearing Nears, New Confirmatory Evidence Sources
|
Oct 14, 2022 |
|
[3分で解説 世界のファーマ] 第6回 レカネマブ、最速ペースで承認へ
|
Oct 14, 2022 |
|
보령의 투 트랙 R&D전략: 혁신신약과 캐시카우
|
Oct 13, 2022 |
|
What To Expect From GSCF’s World Congress 2022, With Judy Stenmark and Nicola Brink
|
Oct 12, 2022 |
|
Scrip’s Five Must-Know Things – 11 October 2022
|
Oct 11, 2022 |
|
Drug Fix: Makena Withdrawal Hearing Nears, In-Person Meetings At US FDA, User Fees Released
|
Oct 07, 2022 |
|
MagGenome Execs Talk Nanoparticle Tech, Indian Cell And Gene Therapy Opportunities
|
Oct 07, 2022 |
|
Chapter 6: About the Authors
|
Oct 06, 2022 |
|
Chapter 5: Final Thoughts
|
Oct 06, 2022 |
|
Chapter 4: What Does the Future Hold for Asia Pacific?
|
Oct 06, 2022 |
|
Chapter 3: Trends Within Asia Pacific Locations
|
Oct 06, 2022 |
|
Chapter 2: The Rise of Asia Pacific
|
Oct 06, 2022 |
|
Chapter 1: An Introduction
|
Oct 06, 2022 |
|
Incoming APACMed chair John Collings Outlines Regional Medtech Priorities
|
Oct 05, 2022 |
|
CEO Podcast with CanSino’s Xuefeng Yu
|
Oct 05, 2022 |
|
Scrip’s Five Must-Know Things – 3 October 2022
|
Oct 03, 2022 |
|
Drug Fix: ALS Drug Cleared, Lecanemab’s Hopeful Alzheimer’s Data, CMS’ Price Negotiation Needs
|
Sep 30, 2022 |
|
Immediate RWD Benefits For Your Early Stage Clinical Studies
|
Sep 29, 2022 |
|
Easing mRNA Manufacturing Bottlenecks – Panel Discussion Highlights Part 2
|
Sep 29, 2022 |
|
Easing mRNA Manufacturing Bottlenecks – Panel Discussion Highlights Part 1
|
Sep 29, 2022 |
|
Understand PDFUA And The Potential Impacts On Public Health
|
Sep 29, 2022 |
|
Overcoming RWD Quality and Curation Pitfalls
|
Sep 29, 2022 |
|
Leveraging RWE To Navigate The Evolving FDA Framework
|
Sep 29, 2022 |
|
Datamonitor oncology analysts discuss key abstracts presented at ESMO 2022
|
Sep 29, 2022 |
|
Chinese Language podcast on Biotech hot topics
|
Sep 27, 2022 |
|
Scrip’s Five Must-Know Things – 26 September 2022
|
Sep 26, 2022 |
|
Drug Fix: Finally, A US FDA User Fee Deal, ‘Pandemic Is Over’ Take-Aways, Tpoxx Development Issues
|
Sep 23, 2022 |
|
Strategies For Encouraging Young, Diverse Talent In Pharma
|
Sep 23, 2022 |
|
【3分で解説 世界のファーマ】第5回 経鼻投与型コロナワクチンの課題は
|
Sep 21, 2022 |
|
Scrip’s Five Must-Know Things – 20 September 2022
|
Sep 20, 2022 |
|
Drug Fix: RWE’s Limited Uses So Far, Learning Pandemic Lessons, COVID-19 Vaccine Reporting Changes
|
Sep 16, 2022 |
|
Medtech Insight’s EU Regulation Basics 2: Key Organizations And Documents And The Four Risk Classes
|
Sep 15, 2022 |
|
Report Digest: Discussing Three Drug Delivery Methods
|
Sep 14, 2022 |
|
Digital Health Roundup: Cardiology, Mobility-Related Agetech, Smart Hospitals, Awards, Fund-Raising
|
Sep 13, 2022 |
|
중국 바이오기업 베이진 (BeiGene)의 글로벌 시장 진출 전략
|
Sep 13, 2022 |
|
Scrip’s Five Must-Know Things – 12 September 2022
|
Sep 12, 2022 |
|
Medtech Monthly: Breakthrough Device Analysis with Bradley Merrill Thompson
|
Sep 09, 2022 |
|
Pink Sheet Podcast: Amylyx’s Adcom Success, Trials Leave Russia, Apolitical Drug Price Negotiations
|
Sep 09, 2022 |
|
Getting Personal With De Oro Devices’ Sidney Collin:‘There’s A Lot Of Learning That Needs To Happen’
|
Sep 08, 2022 |
|
How Sites and Investigators Are Reflecting on Decentralized Trial Models
|
Sep 08, 2022 |
|
Women in healthcare leadership, with Unlocking Eve
|
Sep 05, 2022 |
|
CEO Podcast With InnoCare CEO Jasmine Cui
|
Sep 05, 2022 |
|
Self-Care Regulation After COVID, With Haleon/GSCF’s Ian Urquhart
|
Sep 05, 2022 |
|
Scrip’s Five Must-Know Things – 5 September 2022
|
Sep 05, 2022 |
|
Pink Sheet Podcast: A September To Remember For US FDA, Plus New COVID-19 Boosters And Opioid Plan
|
Sep 02, 2022 |
|
Cell and Gene Therapy
|
Aug 31, 2022 |
|
Day 1 Recap: American Headache Society Annual Scientific Meeting
|
Aug 29, 2022 |
|
Day 2 Recap: American Headache Society Annual Scientific Meeting
|
Aug 29, 2022 |
|
Day 3 Recap: American Headache Society Annual Scientific Meeting
|
Aug 29, 2022 |
|
Post Conference Recap: American Headache Society Annual Scientific Meeting
|
Aug 29, 2022 |
|
Scrip’s Five Must-Know Things – 29 August 2022
|
Aug 29, 2022 |
|
Talking Smart Hospitals With Two Companies Working To Make Them A Reality
|
Aug 23, 2022 |
|
Medtech Insight’s New EU Regulatory/Reimbursement Writer, Eliza Slawther, And EU Basics
|
Aug 23, 2022 |
|
Over the Counter 22 August: Psychedelic Mushrooms With Alkemist Lab CEO Elan Sudberg
|
Aug 22, 2022 |
|
Pink Sheet Podcast: Data Protection, Price Negotiation Enacted, Warning Letters, Amylyx At ICER
|
Aug 19, 2022 |
|
Chinese Language Podcast: Biotech Hot Topics Chat 202208
|
Aug 16, 2022 |
|
Scrip’s Five Must-Know Things – 15 August 2022
|
Aug 15, 2022 |
|
Pink Sheet Podcast: Monkeypox Vaccine EUA, Drug Pricing Bill Fallout, US FDA’s IT Upgrade
|
Aug 12, 2022 |
|
‘신약개발 없이 미래는 없다,’ 유한양행의 오픈이노베이션 전략
|
Aug 09, 2022 |
|
Digital Health Roundup: Cardio Smart Watches, Pear Therapeutics Own Reset, Agetech Boom
|
Aug 09, 2022 |
|
Scrip’s Five Must-Know Things – 8 August 2022
|
Aug 08, 2022 |
|
The ‘Dos and Don’ts’ Of EU Food Supplement Innovation, With Jenson R+’s Mihai Inceu
|
Aug 05, 2022 |
|
Medtech Monthly, Ep. 2: Where Does Diabetes Tech Stand?
|
Aug 03, 2022 |
|
【3分で解説 世界のファーマ】第4回 コロナ治療薬ラゲブリオ アジアで人気の理由とは
|
Aug 02, 2022 |
|
Scrip’s Five Must-Know Things – 1 August 2022
|
Aug 01, 2022 |
|
Pink Sheet Podcast: FDA User Fees, Real-Time Oncology Review, ALS Accelerated Approval, Opioid Suit
|
Jul 29, 2022 |
|
Gennova CEO Singh On India’s mRNA Vaccine, Using Tech Against Cancer, Potential Equity Partnering
|
Jul 27, 2022 |
|
Global Self Care Trends With Johnson & Johnson’s Adam Ricciardone
|
Jul 25, 2022 |
|
Scrip’s Five Must-Know Things – 25 July 2022
|
Jul 25, 2022 |
|
Pink Sheet Podcast: Trial Diversity, More PTAB Issues, US FDA Controlled Substance Leader Elevated
|
Jul 22, 2022 |
|
DCTs: The Future Of Remote Trials
|
Jul 22, 2022 |
|
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
|
Jul 21, 2022 |
|
급변하는 제약바이오 시장, 새로운 M&A 물결이 시작되었나?
|
Jul 20, 2022 |
|
Scrip’s Five Must-Know Things – 18 July 2022
|
Jul 19, 2022 |
|
Citeline Podcast Special: The Shifting Landscape For Drugs And Devices Post-Roe v. Wade
|
Jul 15, 2022 |
|
Pink Sheet Podcast: Novavax Gets EUA, Califf Sets US FDA Departure, Hemophilia Patients Want REMS
|
Jul 15, 2022 |
|
Digital Health Roundup: Solutions For Heart, Loneliness; Diabetes Talks; Post-Roe Legal Advice
|
Jul 11, 2022 |
|
Pink Sheet Podcast: New Drug Pricing Bill, Second Amylyx US FDA Adcom, Skipping A Makena Vote
|
Jul 08, 2022 |
|
Citeline中国生物制药热门话题聊
|
Jul 08, 2022 |
|
Podcast: BD’s Polen Pursues ‘True North’ Path To High-Value Growth
|
Jul 06, 2022 |
|
3分で解説 世界のファーマ 第3回 国際進出を強める韓国企業たち
|
Jul 06, 2022 |
|
Scrip’s Five Must-Know Things – 4 July 2022
|
Jul 04, 2022 |
|
It’s Coming Home: ImmunoACT Advances Plans For Cut-Price CAR-T In India
|
Jun 30, 2022 |
|
The Push For OTC Birth Control With Victoria Nichols
|
Jun 28, 2022 |
|
Scrip’s Five Must-Know Things – 27 June 2022
|
Jun 27, 2022 |
|
Medtech Monthly, Ep. 1: Quality Vs. Compliance
|
Jun 24, 2022 |
|
Post-ASCO Podcast
|
Jun 24, 2022 |
|
Report Digest: Deep Brain and Vagus Nerve Stimulation
|
Jun 22, 2022 |
|
파이낸스 워치: 글로벌 제약바이오업계, 올해 들어 현금 비중 늘리고 인력 감축 파이낸스 워치: 올해1분기 VC의 제약바이오 투자 비중 압도적으로 증가
|
Jun 21, 2022 |
|
Digital Health Roundup: A Mixed Bag Of Exec Interviews; Femtech; Robotics; Digital OR; Wearables
|
Jun 21, 2022 |
|
Scrip’s Five Must-Know Things – 20 June 2022
|
Jun 20, 2022 |
|
3分で解説 世界のファーマ 第2回 FDAの新しい品質管理指標 QMMとは？
|
Jun 15, 2022 |
|
Scrip’s Five Must-Know Things – 13 June 2022
|
Jun 13, 2022 |
|
Interview With Luzsana CEO Scott Filosi And CMO Joseph Eid
|
Jun 09, 2022 |
|
Reusable Packaging For Consumer Health Goods With Annika Greve
|
Jun 08, 2022 |
|
Scrip’s Five Must-Know Things – 6 June 2022
|
Jun 06, 2022 |
|
Device Week, 2 June 2022 – Robot Blood Draws? Diabetes Upheavals
|
Jun 02, 2022 |
|
Speaking Of Medtech, Ep. 9: The Case For Compliance
|
Jun 02, 2022 |
|
보스턴으로 몰리는 한국 제약바이오업계의 기회와 도전
|
Jun 01, 2022 |
|
Ellie Davenport, Summer Colling, and Kripa Krishnan discuss the psychiatric disorder market
|
May 30, 2022 |
|
Scrip’s Five Must-Know Things – 30 May 2022
|
May 30, 2022 |
|
Pink Sheet Podcast Crossover Special: Assessing FDA Commissioner Robert Califf’s First 100 Days
|
May 27, 2022 |
|
Three-Minute Japanese-Language Article Summary
|
May 25, 2022 |
|
OTC Monograph Reform: A Conversation With CHPA’s Barbara Kochanowski and David Spangler
|
May 23, 2022 |
|
Scrip’s Five Must-Know Things – 23 May 2022
|
May 23, 2022 |
|
EU MedTech Forum 2022: Regulatory Predictability Impacts Renewed Calls For Devices Agency
|
May 20, 2022 |
|
A Clinical Trial Hot Spot: Australia’s Attractions For Korean Firms
|
May 19, 2022 |
|
Cybin CEO: Big Pharma Can No Longer Sit On The Sidelines In Psychedelics
|
May 17, 2022 |
|
Digital Health Roundup – AI Trends In Medtech; Exec Chats; FDA’s Digital Health Guru Steps Down
|
May 16, 2022 |
|
Scrip’s Five Must-Know Things – 16 May 2022
|
May 16, 2022 |
|
Pink Sheet Podcast: FDA User Fee Bill Mark-Up, Postmarket Quality Requirements, Fewer Adcom Meetings
|
May 13, 2022 |
|
How Ex-Janssen India Chief Is Steering Bharat Serums’ Ambitions In Women’s Health
|
May 13, 2022 |
|
Report Digest: Discussing What's Going On With Prostate Cancer Diagnosis And Treatment
|
May 12, 2022 |
|
Scrip’s Five Must-Know Things – 9 May 2022
|
May 09, 2022 |
|
Pink Sheet Podcast: House User Fee Bill, Push For OTC Naloxone, SCOTUS Overturning Roe v. Wade
|
May 06, 2022 |
|
The Landscape Of Naloxone Access With HRT’s Michael Hufford
|
May 06, 2022 |
|
Which COVID Trends Are Here To Stay? With IQVIA Consumer Health’s Prasanna Pitale
|
May 03, 2022 |
|
Pink Sheet Podcast: Young Children’s COVID Vaccines, Aduhelm Coverage Criticism, McKinsey Conflicts
|
Apr 29, 2022 |
|
The EU HTA Regulation: How It Threatens Device Launches And Where The Solutions Lie
|
Apr 29, 2022 |
|
CEO Podcast – CANbridge’s James Xue Talks To Scrip On Plans And Strategy
|
Apr 27, 2022 |
|
Scrip’s Five Must-Know Things – 25 April 2022
|
Apr 25, 2022 |
|
Exploring The Intersection Of Skincare, AI, And Business With Sampo Parkkinen
|
Apr 22, 2022 |
|
Pink Sheet Podcast: COVID-19 Vaccine Boosters, Clinical Trial Diversity, FDA Returns To The Office
|
Apr 22, 2022 |
|
Zydus Lifesciences MD Sharvil Patel On Rare Disease Focus, New Corporate Identity, COVID Vaccine
|
Apr 21, 2022 |
|
Q1 Consumer Health Earnings Preview, With HBW’s Malcom Spicer And Tom Gallen
|
Apr 19, 2022 |
|
Scrip’s Five Must-Know Things – 18 April 2022
|
Apr 18, 2022 |
|
Device Week, 13 April 2022 –Miach And Outset Exec Chats; Medtronic Updates Renal Denervation Trials
|
Apr 13, 2022 |
|
Digital Health Roundup – March Mad About Medtech Conferences; Telehealth Legislation
|
Apr 12, 2022 |
|
Scrip’s Five Must-Know Things – 11 April 2022
|
Apr 11, 2022 |
|
Sustainability In The U.S. Cosmetics Industry With Ryan Nelson
|
Apr 08, 2022 |
|
Scrip’s Five Must-Know Things – 4 April 2022
|
Apr 04, 2022 |
|
Device Week, 1 April 2022 – MDUFA V Heads To Capitol Hill
|
Apr 01, 2022 |
|
Pink Sheet Podcast: Amylyx Adcom Take-Aways, FDA Budget Request, Aduhelm Coverage Advocacy
|
Apr 01, 2022 |
|
What To Expect From The 58th AESGP Annual Meeting, With Jurate Švarcaite
|
Mar 28, 2022 |
|
Scrip’s Five Must-Know Things – 28 March 2022
|
Mar 28, 2022 |
|
Scrip’s Five Must-Know Things – 22 March 2022
|
Mar 22, 2022 |
|
The 2022 Pharma R&D Review Audio Book
|
Mar 21, 2022 |
|
Pink Sheet Podcast: Aduhelm Coverage Campaign, Drug Pricing Reform Future, COVID-19 Impact At US FDA
|
Mar 18, 2022 |
|
Speaking Of Medtech, Ep. 8: Medical Device Quality
|
Mar 17, 2022 |
|
EU Post-Market Surveillance: How Doing More Than Minimum Benefits Medtech
|
Mar 17, 2022 |
|
Pharma R&D 2022 - Chapter 8 - Wonders of the Modern World
|
Mar 15, 2022 |
|
Pharma R&D 2022 - Chapter 7 - Planes, Trains and Automobiles: Types of Pipeline Drugs
|
Mar 15, 2022 |
|
Pharma R&D 2022 - Chapter 6 - The Road Less Travelled: Mechanisms and Targets
|
Mar 15, 2022 |
|
Pharma R&D 2022 - Chapter 5 - Taking in the Varied Scenery: Top Therapies
|
Mar 15, 2022 |
|
Pharma R&D 2022 - Chapter 4 - Meet Your Fellow Travelers: Top Companies
|
Mar 15, 2022 |
|
Pharma R&D 2022 - Chapter 3 - Arrival: The 2022 Pipeline by Phase
|
Mar 15, 2022 |
|
Pharma R&D 2022 - Chapter 1 - Introduction
|
Mar 15, 2022 |
|
Pharma R&D 2022 - Chapter 2 - Checked-In and Ready for Take Off
|
Mar 15, 2022 |